|
US5853719A
(en)
*
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
JP3869092B2
(ja)
*
|
1996-10-01 |
2007-01-17 |
ジェロン・コーポレーション |
ヒトテロメラーゼ触媒性サブユニット
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US20050169898A1
(en)
*
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
|
US20020041868A1
(en)
*
|
1997-04-15 |
2002-04-11 |
Charles Nicolette |
Cell fusions and methods of making and using the same
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US6977074B2
(en)
*
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US7402307B2
(en)
*
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
JP2002509716A
(ja)
|
1998-03-31 |
2002-04-02 |
ユニバーシティ テクノロジー コーポレイション |
テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物
|
|
US20040247662A1
(en)
*
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030022854A1
(en)
*
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
FR2785542B1
(fr)
*
|
1998-11-06 |
2001-02-09 |
Pf Medicament |
UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
|
|
US7713739B1
(en)
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
EP1436413A2
(en)
*
|
2000-10-24 |
2004-07-14 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
|
US20030059834A1
(en)
*
|
2001-02-01 |
2003-03-27 |
Chang Nancy T. |
Methods to generate and identify monoclonal antibodies to a large number of human antigens
|
|
DE10112851C1
(de)
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
CA2448599A1
(en)
*
|
2001-04-27 |
2002-11-07 |
Xcyte Therapies, Inc. |
Maturation of antigen-presenting cells using activated t cells
|
|
GB0111015D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Norsk Hydro As |
Genetic material
|
|
ATE464317T1
(de)
|
2001-06-05 |
2010-04-15 |
Curevac Gmbh |
Stabilisierte mrna mit erhöhtem g/c-gehalt für die gentherapie
|
|
WO2003023026A1
(en)
*
|
2001-09-06 |
2003-03-20 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
EP1442125A4
(en)
*
|
2001-10-04 |
2004-12-08 |
Carlos Estuard Aguilar-Cordova |
CHIMERAL VIRUS VECTORS FOR GENE THERAPY
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
CA2491574A1
(en)
*
|
2002-07-05 |
2004-01-15 |
Duke University |
Angio-immunotherapy
|
|
WO2004016803A2
(en)
*
|
2002-08-14 |
2004-02-26 |
Duke University |
Method of enhancing cd4+ t cell responses
|
|
CN101139393B
(zh)
|
2002-09-12 |
2010-11-24 |
肿瘤疗法科学股份有限公司 |
Kdr肽和包括该肽的疫苗
|
|
US7785583B2
(en)
*
|
2002-12-10 |
2010-08-31 |
Argos Therapeutics, Inc. |
In situ maturation of dendritic cells
|
|
EP1585812B1
(en)
|
2002-12-13 |
2017-01-18 |
Alphavax, Inc. |
Multi-antigenic alphavirus replicon particles and methods
|
|
BRPI0317276B8
(pt)
*
|
2002-12-13 |
2021-05-25 |
Alphavax Inc |
método para a preparação de partículas de replicon de alfavírus (arps)
|
|
JP2006518219A
(ja)
*
|
2003-02-18 |
2006-08-10 |
マックスサイト インコーポレーティッド |
電気穿孔法による細胞への抗原の負荷方法
|
|
US20060134067A1
(en)
*
|
2003-02-18 |
2006-06-22 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
WO2004073641A2
(en)
|
2003-02-18 |
2004-09-02 |
Kevin Slawin |
Induced activation in dendritic cells
|
|
WO2004085660A2
(en)
*
|
2003-03-20 |
2004-10-07 |
Alphavax, Inc. |
Improved alphavirus replicons and helper constructs
|
|
AU2004257214B2
(en)
*
|
2003-07-11 |
2010-04-22 |
Alphavax, Inc. |
Alphavirus-based cytomegalovirus vaccines
|
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
WO2005052128A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Argos Therapeutics, Inc. |
Mrna transfected antigen presenting cells
|
|
US20050181035A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
EP1730263A4
(en)
*
|
2004-03-02 |
2008-01-23 |
Tsuneya Ohno |
METHODS AND COMPOSITIONS RELATING TO HYBRID CELL VACCINES FOR TREATMENT AND CANCER PREVENTION
|
|
US20050266550A1
(en)
|
2004-05-18 |
2005-12-01 |
Alphavax, Inc. |
TC-83-derived alphavirus vectors, particles and methods
|
|
US20080293581A1
(en)
*
|
2004-05-24 |
2008-11-27 |
Rogler Charles E |
Rna Expression Microarrays
|
|
CA2504451A1
(en)
*
|
2004-08-10 |
2006-02-10 |
Geron Corporation |
Dendritic cell vaccines for treating cancer made from embryonic stem cells
|
|
AU2005284922B2
(en)
|
2004-09-14 |
2010-12-23 |
Coimmune, Inc. |
Strain independent amplification of pathogens and vaccines thereto
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
US20060216269A1
(en)
*
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
GB0501129D0
(en)
*
|
2005-01-19 |
2005-02-23 |
Ribostem Ltd |
Method of treatment by administration of RNA
|
|
PT2325306E
(pt)
|
2005-02-25 |
2014-04-29 |
Oncotherapy Science Inc |
Vacinas peptídicas para cancros do pulmão que expressam polipéptidos ttk, urlc10 ou koc1
|
|
US7919099B2
(en)
|
2005-02-28 |
2011-04-05 |
Oncotherapy Science, Inc. |
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
|
|
ES2650569T3
(es)
|
2005-04-08 |
2018-01-19 |
Argos Therapeutics, Inc. |
Composiciones de células dendríticas y métodos
|
|
PL1910839T3
(pl)
|
2005-07-27 |
2016-11-30 |
|
Gen TOM34 związany z nowotworem okrężnicy
|
|
CA2626238C
(en)
|
2005-10-17 |
2015-10-06 |
Sloan Kettering Institute For Cancer Research |
Wt1 hla class ii-binding peptides and compositions and methods comprising same
|
|
WO2007120673A2
(en)
|
2006-04-10 |
2007-10-25 |
Sloan Kettering Institute For Cancer Research |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US20070281336A1
(en)
|
2006-04-14 |
2007-12-06 |
Epicentre Technologies |
Kits and methods for generating 5' capped RNA
|
|
SI2051987T1
(sl)
|
2006-08-18 |
2015-02-27 |
Argos Therapeutics, Inc. |
Uporaba cd83 v kombinacijskih terapijah
|
|
KR101527473B1
(ko)
|
2006-10-17 |
2015-06-17 |
온코세라피 사이언스 가부시키가이샤 |
Ｍｐｈｏｓｐｈ1 또는 ｄｅｐｄｃ1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
|
|
CA2666667C
(en)
*
|
2006-10-19 |
2023-06-20 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
|
WO2008055354A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Université de Montréal |
Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
|
|
TWI615403B
(zh)
|
2007-02-21 |
2018-02-21 |
腫瘤療法 科學股份有限公司 |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
TWI434853B
(zh)
|
2007-04-11 |
2014-04-21 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
|
|
DK2183368T3
(en)
*
|
2007-06-21 |
2016-09-05 |
Alphavax Inc |
PROMOTER-FREE CASES FOR EXPRESSION OF ALPHAVIRUS STRUCTURE PROTEINS
|
|
CN108117584B
(zh)
|
2007-08-20 |
2021-08-24 |
肿瘤疗法科学股份有限公司 |
Foxm1肽和包含foxm1肽的药剂
|
|
US8513208B2
(en)
*
|
2008-02-28 |
2013-08-20 |
Argos Therapeutics, Inc. |
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
CN102123732A
(zh)
|
2008-06-20 |
2011-07-13 |
杜克大学 |
用于引发免疫应答的组合物，方法及试剂盒
|
|
ES2840750T3
(es)
|
2008-09-22 |
2021-07-07 |
Baylor College Medicine |
Métodos y composiciones para generar una respuesta inmune induciendo CD40 y adaptadores del receptor de reconocimiento de patrones
|
|
AU2009317161B2
(en)
|
2008-11-24 |
2014-09-11 |
Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt Gmbh |
High affinity T cell receptor and use thereof
|
|
TWI539160B
(zh)
|
2008-12-05 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
|
|
WO2010065876A2
(en)
|
2008-12-06 |
2010-06-10 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to th-1 dendritic cells
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
RU2733985C2
(ru)
|
2009-03-18 |
2020-10-09 |
Онкотерапи Сайенс, Инк. |
Пептиды neil3 и включающие их вакцины
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
AU2011225577B2
(en)
|
2010-03-11 |
2017-01-19 |
Oncotherapy Science, Inc. |
HJURP peptides and vaccines including the same
|
|
TW201627003A
(zh)
|
2010-04-02 |
2016-08-01 |
腫瘤療法 科學股份有限公司 |
Ｅｃｔ２胜肽及含此胜肽之疫苗
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
EP3578205A1
(en)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
|
HUE069586T2
(hu)
|
2010-10-01 |
2025-03-28 |
Modernatx Inc |
Módosított nukleozidok, nukleotidok és nukleinsavak, valamint ezek felhasználása
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
MX350220B
(es)
|
2011-08-12 |
2017-08-30 |
Oncotherapy Science Inc |
Peptidos de mphosph1 y vacunas que incluyen los mismos.
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DK3682905T3
(da)
|
2011-10-03 |
2022-02-28 |
Modernatx Inc |
Modificerede nukleosider, nukleotider og nukleinsyrer og anvendelser deraf
|
|
DK3296317T3
(da)
|
2011-10-28 |
2020-02-24 |
Oncotherapy Science Inc |
Topk-peptider og vacciner, der indbefatter disse
|
|
HRP20220717T1
(hr)
|
2011-12-16 |
2022-07-22 |
Modernatx, Inc. |
Modificirani pripravci mrna
|
|
CN104684577B
(zh)
|
2012-01-13 |
2018-05-08 |
纪念斯隆凯特林癌症中心 |
免疫原性wt-1肽及其使用方法
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
JP6189415B2
(ja)
|
2012-04-02 |
2017-08-30 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
細胞質および細胞骨格タンパク質の産生のための修飾ポリヌクレオチド
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
EP2872530A4
(en)
|
2012-07-10 |
2016-04-06 |
Oncotherapy Science Inc |
KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
|
|
EP2922554B1
(en)
|
2012-11-26 |
2022-02-23 |
ModernaTX, Inc. |
Terminally modified rna
|
|
DK2945647T3
(da)
|
2013-01-15 |
2020-11-16 |
Memorial Sloan Kettering Cancer Center |
Immunogene wt-1-peptider og anvendelsesmetoder deraf
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Ｋｎｔｃ２胜肽及含此胜肽之疫苗
|
|
JP6541639B2
(ja)
|
2013-03-14 |
2019-07-10 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
Ｔ細胞増殖をコントロールするための方法
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
DK3004329T3
(da)
|
2013-06-05 |
2020-05-18 |
Bellicum Pharmaceuticals Inc |
Fremgangsmåder til induktion af delvis apoptose under anvendelse af caspasepolypeptider
|
|
HK1226299A1
(zh)
|
2013-09-24 |
2017-09-29 |
Duke University |
用於诱发免疫反应的组合物、方法及工具
|
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
WO2015062738A1
(en)
|
2013-11-01 |
2015-05-07 |
Curevac Gmbh |
Modified rna with decreased immunostimulatory properties
|
|
US10934346B2
(en)
|
2014-02-14 |
2021-03-02 |
Bellicum Pharmaceuticals, Inc. |
Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
|
|
US9610358B2
(en)
*
|
2014-04-17 |
2017-04-04 |
Marker Gene Technologies, Inc |
Targeted pharmacological chaperones
|
|
US12214038B2
(en)
*
|
2014-07-22 |
2025-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for cancer immunotherapy
|
|
US10676514B2
(en)
|
2014-08-04 |
2020-06-09 |
Oncotherapy Science, Inc. |
CDCA1-derived peptide and vaccine containing same
|
|
EP3590954A3
(en)
|
2014-08-04 |
2020-03-25 |
OncoTherapy Science, Inc. |
Koc1-derived peptide and vaccine including same
|
|
IL250235B
(en)
|
2014-08-04 |
2022-07-01 |
Oncotherapy Science Inc |
A peptide derived from urlc10 and a component containing it
|
|
EP3189148A4
(en)
|
2014-09-02 |
2018-05-02 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
CA2961749C
(en)
*
|
2014-09-17 |
2021-01-12 |
The Johns Hopkins University |
Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells
|
|
CA2965347C
(en)
*
|
2014-10-27 |
2023-03-14 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for boosting the efficacy of adoptive cellular immunotherapy
|
|
CA2966300C
(en)
|
2014-11-03 |
2023-07-11 |
Mirjam H.M. Heemskerk |
T cell receptors directed against bob1 and uses thereof
|
|
JP2018090491A
(ja)
*
|
2015-04-01 |
2018-06-14 |
株式会社細胞治療技術研究所 |
癌ワクチンの製造方法、及び癌ワクチン
|
|
US11090332B2
(en)
*
|
2015-05-21 |
2021-08-17 |
Regen BioPharma, Inc. |
Antigen specific mRNA cellular cancer vaccines
|
|
JP6666094B2
(ja)
*
|
2015-09-15 |
2020-03-13 |
株式会社東芝 |
吸着支持装置、および物品把持装置
|
|
SG10201913659SA
(en)
|
2015-10-08 |
2020-03-30 |
Oncotherapy Science Inc |
Foxm1-derived peptide, and vaccine including same
|
|
EP3410849B1
(en)
|
2016-02-05 |
2023-07-05 |
Institut Pasteur |
Use of inhibitors of adam12 as adjuvants in tumor therapies
|
|
CA3022267A1
(en)
|
2016-05-04 |
2017-11-09 |
Fred Hutchinson Cancer Research Center |
Cell-based neoantigen vaccines and uses thereof
|
|
EP3478073B1
(en)
*
|
2016-06-29 |
2025-11-26 |
Duke University |
Compositions and methods for activating antigen presenting cells with chimeric poliovirus
|
|
US20210069310A1
(en)
*
|
2018-01-05 |
2021-03-11 |
Rolf Jonas Andreas NILSSON |
Endogenous tumor-derived circular rna and proteins thereof for use as vaccine
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
US20250144143A1
(en)
*
|
2023-11-06 |
2025-05-08 |
Immunitybio, Inc. |
Virally Educated T cells
|